Mycobacteria, nocardioform, and other actinomycetes are a group of bacteria that pose significant challenges in susceptibility testing. These organisms have complex growth requirements and are often resistant to multiple antimicrobial agents, making susceptibility testing more difficult.
| Source | Details | |---|---| | | The primary source. Members can access the document at a reduced price. Non-members can purchase it directly. As an archived document, it will be less expensive than active standards. Visit clsi.org and search for "M22-A3" or "M22A3E". | | ANSI Webstore | The American National Standards Institute (ANSI) is a key partner. The PDF purchased through ANSI is the official CLSI document. Visit webstore.ansi.org . | | Accuris (formerly Techstreet) | A major standards distributor. They typically offer a "Printed Edition + PDF" package for immediate download. However, note that the CLSI no longer offers a print edition for this specific document. | | Intertek Inform | Another reputable source for purchasing standards, offering both hardcopy and PDF formats. |
Provides specific incubation conditions for media quality control.
: Users must still perform visual inspections for physical defects (e.g., dehydration, bubbles, or contamination) and monitor storage conditions, even for exempt media. Document Structure
All QC results must be logged. If a medium batch fails any parameter, the entire lot must be rejected, and the failure must be reported to the manufacturer. Evolution and the Transition to M22-A4
Manufacturers must produce media according to strict quality systems, testing every lot for sterility, growth performance, and selectivity before shipping.
: Guidelines for preparing inoculum (such as matching a 0.5 McFarland standard) and isolation streaking methods for quality verification. Key Specifications